Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 7970 | 285.695 |
09:36 ET | 100 | 286.84 |
09:39 ET | 1200 | 285.72 |
09:41 ET | 894 | 286.885 |
09:43 ET | 700 | 287.1 |
09:45 ET | 375 | 287.35 |
09:48 ET | 400 | 288.01 |
09:50 ET | 785 | 286.64 |
09:52 ET | 300 | 287.155 |
09:54 ET | 1200 | 287.77 |
09:56 ET | 1500 | 287.075 |
09:57 ET | 945 | 287.045 |
09:59 ET | 500 | 286.84 |
10:01 ET | 2011 | 288.17 |
10:06 ET | 4335 | 289.555 |
10:08 ET | 3436 | 289.67 |
10:10 ET | 2442 | 289.615 |
10:12 ET | 705 | 289.85 |
10:14 ET | 3200 | 289.925 |
10:15 ET | 1200 | 290.35 |
10:17 ET | 200 | 290.01 |
10:19 ET | 2925 | 290.215 |
10:21 ET | 200 | 290.14 |
10:24 ET | 200 | 289.93 |
10:26 ET | 500 | 290.35 |
10:28 ET | 841 | 290.6 |
10:30 ET | 2037 | 290.5 |
10:32 ET | 700 | 290.005 |
10:33 ET | 1000 | 289.325 |
10:35 ET | 1139 | 290.07 |
10:37 ET | 600 | 290.14 |
10:39 ET | 100 | 290.4 |
10:42 ET | 555 | 290.835 |
10:44 ET | 800 | 290.725 |
10:46 ET | 5547 | 290.58 |
10:53 ET | 430 | 290.86 |
10:55 ET | 910 | 291.02 |
10:57 ET | 100 | 291.24 |
11:00 ET | 100 | 291.075 |
11:02 ET | 595 | 291.0927 |
11:04 ET | 1403 | 291.185 |
11:06 ET | 800 | 291.45 |
11:09 ET | 331 | 291.455 |
11:11 ET | 5699 | 291.325 |
11:13 ET | 1692 | 291.93 |
11:15 ET | 4379 | 293.73 |
11:18 ET | 1467 | 293.275 |
11:22 ET | 200 | 293.165 |
11:24 ET | 600 | 293.515 |
11:26 ET | 5324 | 293.48 |
11:27 ET | 2300 | 293.9899 |
11:29 ET | 3328 | 294.11 |
11:31 ET | 100 | 293.9 |
11:33 ET | 426 | 294.05 |
11:36 ET | 100 | 293.855 |
11:38 ET | 3500 | 294.05 |
11:40 ET | 446 | 294.23 |
11:44 ET | 100 | 294.275 |
11:45 ET | 504 | 294.45 |
11:47 ET | 1000 | 294.66 |
11:49 ET | 1400 | 294.91 |
11:51 ET | 800 | 294.88 |
11:54 ET | 8137 | 294.525 |
11:56 ET | 1883 | 294.545 |
11:58 ET | 300 | 294.545 |
12:00 ET | 300 | 294.65 |
12:02 ET | 771 | 294.66 |
12:03 ET | 930 | 294.89 |
12:05 ET | 1200 | 295.02 |
12:07 ET | 650 | 295.51 |
12:09 ET | 300 | 295.13 |
12:12 ET | 100 | 295.26 |
12:14 ET | 107 | 295.25 |
12:16 ET | 300 | 295.49 |
12:18 ET | 10171 | 295.29 |
12:20 ET | 3578 | 294.355 |
12:21 ET | 1600 | 294.51 |
12:23 ET | 2164 | 294.505 |
12:25 ET | 300 | 294.99 |
12:27 ET | 200 | 295.4 |
12:30 ET | 4151 | 295.54 |
12:32 ET | 200 | 295.77 |
12:34 ET | 200 | 295.67 |
12:36 ET | 300 | 295.905 |
12:38 ET | 1044 | 296.0885 |
12:39 ET | 3682 | 295.93 |
12:41 ET | 2602 | 294.96 |
12:43 ET | 200 | 294.855 |
12:45 ET | 600 | 294.715 |
12:48 ET | 600 | 294.9295 |
12:50 ET | 200 | 294.84 |
12:52 ET | 600 | 295.7 |
12:56 ET | 200 | 295.47 |
12:57 ET | 125 | 295.95 |
12:59 ET | 404 | 295.665 |
01:01 ET | 2593 | 295.91 |
01:06 ET | 2707 | 295.755 |
01:10 ET | 100 | 295.73 |
01:12 ET | 3858 | 295.58 |
01:14 ET | 200 | 295.37 |
01:15 ET | 1000 | 295.425 |
01:17 ET | 200 | 295.56 |
01:19 ET | 400 | 295.6 |
01:21 ET | 483 | 295.54 |
01:24 ET | 1500 | 295.68 |
01:26 ET | 300 | 295.725 |
01:28 ET | 800 | 295.78 |
01:30 ET | 400 | 295.94 |
01:32 ET | 22760 | 295.66 |
01:33 ET | 675 | 295.58 |
01:35 ET | 700 | 295.33 |
01:37 ET | 100 | 295.32 |
01:39 ET | 1000 | 295.925 |
01:42 ET | 500 | 295.98 |
01:44 ET | 500 | 296.115 |
01:46 ET | 818 | 296 |
01:48 ET | 200 | 295.995 |
01:50 ET | 600 | 296.14 |
01:51 ET | 100 | 296.07 |
01:53 ET | 2300 | 296.01 |
01:55 ET | 200 | 296.09 |
02:00 ET | 2000 | 296.22 |
02:02 ET | 700 | 296.05 |
02:04 ET | 2386 | 296.085 |
02:06 ET | 100 | 296.45 |
02:08 ET | 100 | 296.555 |
02:09 ET | 2171 | 296.42 |
02:13 ET | 700 | 296.85 |
02:15 ET | 700 | 297.025 |
02:18 ET | 601 | 296.94 |
02:20 ET | 500 | 297.08 |
02:24 ET | 1134 | 297.08 |
02:26 ET | 1121 | 297.155 |
02:27 ET | 200 | 297.185 |
02:29 ET | 4624 | 296.38 |
02:31 ET | 200 | 296.5 |
02:33 ET | 244 | 296.68 |
02:36 ET | 500 | 296.29 |
02:38 ET | 1879 | 296.13 |
02:42 ET | 600 | 296.12 |
02:44 ET | 100 | 296.085 |
02:45 ET | 1000 | 295.87 |
02:47 ET | 1100 | 295.75 |
02:49 ET | 400 | 295.765 |
02:51 ET | 2531 | 296.07 |
02:54 ET | 600 | 296.075 |
02:56 ET | 100 | 295.995 |
02:58 ET | 1502 | 296.12 |
03:02 ET | 402 | 296.14 |
03:03 ET | 400 | 296.045 |
03:05 ET | 200 | 296.035 |
03:07 ET | 200 | 296.21 |
03:09 ET | 200 | 296.24 |
03:14 ET | 1100 | 296.27 |
03:16 ET | 4118 | 295.955 |
03:18 ET | 789 | 296.04 |
03:20 ET | 200 | 296.15 |
03:21 ET | 1308 | 296.495 |
03:23 ET | 718 | 296.65 |
03:25 ET | 100 | 296.58 |
03:27 ET | 505 | 296.64 |
03:30 ET | 525 | 296.56 |
03:32 ET | 1456 | 296.635 |
03:34 ET | 400 | 296.7 |
03:36 ET | 1900 | 296.98 |
03:38 ET | 1700 | 296.92 |
03:39 ET | 1400 | 296.98 |
03:41 ET | 6951 | 297.225 |
03:43 ET | 4300 | 297.535 |
03:45 ET | 2446 | 297.67 |
03:48 ET | 4414 | 297.09 |
03:50 ET | 3649 | 296.77 |
03:52 ET | 2286 | 296.475 |
03:54 ET | 4277 | 296.62 |
03:56 ET | 6358 | 296.935 |
03:57 ET | 7348 | 297.16 |
03:59 ET | 103210 | 297.06 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 12.8B | 14.1x | +8.22% |
Medpace Holdings Inc | 12.2B | 40.3x | +35.10% |
Biomarin Pharmaceutical Inc | 15.9B | 80.5x | --- |
Neurocrine Biosciences Inc | 13.6B | 37.2x | +62.04% |
Qiagen NV | 9.4B | 28.7x | +12.66% |
Beigene Ltd | 17.9B | -21.1x | --- |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.8B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.54 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 14.1x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | 11.6x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.